cannabinoid-based therapy (Novaliq)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecannabinoid-based therapy (Novaliq)
Drug Alias Name45603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsXerophthalmiaNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovaliq Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovaliq Gmbh
Active IndicationsN/A
Inactive IndicationsXerophthalmiaNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A